Evidence-Based Compounds for Alzheimer's
Alzheimer's disease involves amyloid-beta accumulation, tau hyperphosphorylation, neuroinflammation, and mitochondrial dysfunction. Research identifies compounds with evidence for reducing amyloid burden, supporting acetylcholine metabolism, promoting neuronal survival, and modulating neuroinflammatory pathways. These should be considered adjuncts to medical care.
This page presents computational analysis of published research from PubMed/NCBI, BindingDB, and Reactome. Rankings are based on BiohacksAI discovery score, pathway overlap, and study count. This is not medical advice — consult a healthcare professional before starting any supplement.
Browse all compounds · Biological pathways · Molecular targets · All conditions
© Organiq Sweden AB · Patent pending EVE-PAT-2026-001